Plant‐Made Vaccines Targeting Enteric Pathogens—Safe Alternatives for Vaccination in Developing Countries
Biotechnology and Bioengineering · 2025
DOI: 10.1002/bit.28876 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biotechnology and Bioengineering, 2025. Verfasst von Edgar Trujillo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Immunology & Vaccinology Group. Centro de Investigaciones Biológicas del Noroeste, S.C. (CIBNOR). Instituto Politécnico Nacional 195, Playa Palo de S…. Hauptthemen laut MEDLINE: Plants, Genetically Modified, Vaccines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 207 Literaturangaben. Gefördert von: This work was supported by CONAHCYT/Mexico Postdoctoral Fellowship (565899) for Edgar Trujillo..
Abstract (Originalsprache)
Enteric diseases by pathogenic organisms are one of the leading causes of death worldwide, particularly in low‐income countries. Despite antibiotics, access to clean water and vaccination are the most economically affordable options to prevent those infections and their health consequences. Vaccines, such as those approved for rotavirus and cholera, have played a key role in preventing several enteric diseases. However, vaccines for other pathogens are still in clinical trials. Distribution and cost remain significant barriers to vaccine access in developing regions due to poor healthcare infrastructure, cold‐chain requirements, and high production costs. Plant‐made vaccines offer a promising alternative to address these challenges. Plants can be easily grown, lowering production costs, and can be administered in oral forms, potentially eliminating cold‐chain dependency. Although there are some promising prototypes of vaccines produced in plants, challenges remain, including yields and achieving sufficient immunogenicity. This review aims to describe common enteric pathogens and available vaccines, followed by a strategic summary of plant‐made vaccine development and a discussion of plant‐made enteric vaccine prototypes. Trends to overcome the key challenges for plant‐made vaccines are identified and placed in perspective for the development of affordable and effective vaccines for populations at the highest risk of enteric diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology & Vaccinology Group. Centro de Investigaciones Biológicas del Noroeste, S.C. (CIBNOR). Instituto Politécnico Nacional 195, Playa Palo de Santa Rita Sur, La Paz, B.C.S., México.
ORCID-Profile: Carlos Angulo
Förderung
- This work was supported by CONAHCYT/Mexico Postdoctoral Fellowship (565899) for Edgar Trujillo.
Zitieren
APA
Trujillo, E., & Angulo, C. (2025). Plant‐Made Vaccines Targeting Enteric Pathogens—Safe Alternatives for Vaccination in Developing Countries. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28876
Vancouver
Trujillo E, Angulo C. Plant‐Made Vaccines Targeting Enteric Pathogens—Safe Alternatives for Vaccination in Developing Countries. Biotechnology and Bioengineering. 2025. doi:10.1002/bit.28876
BibTeX
@article{Trujillo2025,
author = {Trujillo, Edgar and Angulo, Carlos},
title = {Plant‐Made Vaccines Targeting Enteric Pathogens—Safe Alternatives for Vaccination in Developing Countries},
journal = {Biotechnology and Bioengineering},
year = {2025},
doi = {10.1002/bit.28876}
}
EUVIMED